- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07699263
Effect of an Occlusal Splint in Swimming Performance
Effect of a Customized Occlusal Splint on Athletic Performance in Master Swimmers: A Randomized Pilot Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46003
- Universidad Europea de Valencia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
To be eligible for inclusion, participants had to be between 20 and 40 years of age, actively participating in regular swimming training, free from acute or chronic injuries, and willing to comply with the study protocol. Exclusion criteria included use of performance-enhancing substances, presence of systemic diseases, current use of medication affecting performance, active orthodontic appliances, temporomandibular joint disorders, pregnancy, or failure to complete the study protocol.
(It won't let me add the flowchart image, so I'll describe it below)
- Participamos assessed for eligibility (n=24)
- Excluded (n=4) 2.1 Did not Meet inclusion criteria (n=3) 2.2 Did not provide informed consent (n=1)
- Randomized (n=20) 3.1 Intervention group (case) (n=10) 3.1.1 Lost to follow-up (n=0) 3.1.2 Analyzed (n=10) 3.2 Control group (n=10) 3.2.1 Lost to follow-up (n=0) 3.2.2 Analyzed (n=10)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: intervention group, which used a customized occlusal splint
|
occlusal Splint
|
|
Other: control group, which continued training without a splint
|
occlusal Splint
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
swimming performance
Time Frame: Measurements were taken during the training sessions, in day 1
|
swimming performance was quantified as pace in 100 meters and 50 meters freestyle, both measured in seconds with a digital stopwatch (SRUIS, ZSD013, France).
For each participant and distance, three consecutive trials were recorded under standardized conditions, and averaged for statistical analysis
|
Measurements were taken during the training sessions, in day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke efficiency
Time Frame: Measurements were taken during the training sessions, in day 1
|
Stroke efficiency was measured as the number of strokes per 25 meters, determined by direct observation and manual counting by two externals observers
|
Measurements were taken during the training sessions, in day 1
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular efficiency
Time Frame: Measurements were taken during the training sessions, in day 1
|
Cardiovascular efficiency was assessed as maximum heart rate measured in beats per minute using a chest strap sensor (Garmin HRM-Pro-Plus), synchronized with a receiver unit (Garmin Forerunner 255s)
|
Measurements were taken during the training sessions, in day 1
|
|
Maximum heart rate
Time Frame: Measurements were taken during the training sessions, in day 1
|
Maximum heart rate was operationally defined as the highest value recorded during maximal effort testing
|
Measurements were taken during the training sessions, in day 1
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-520
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on occlusal splint
-
Baskent UniversityRecruiting
-
Istanbul UniversityCompleted
-
University of Sao Paulo General HospitalRecruitingTinnitus | Temporomandibular Disorders (TMD) | TMJBrazil
-
Cairo UniversityRecruitingPediatric Mandibular FractureEgypt
-
Nigde Omer Halisdemir UniversityRecruitingBruxism | Bruxism, Sleep-RelatedTurkey (Türkiye)
-
Istanbul UniversityBandırma Onyedi Eylül UniversityCompletedTemporomandibular Disorders (TMD) | Occlusal SplintsTurkey (Türkiye)
-
Okan UniversityNot yet recruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedTemporomandibular Disorders (TMD)Portugal
-
Cairo UniversityNot yet recruiting
-
Johns Hopkins UniversityNot yet recruitingMalocclusion, Angle Class II | Malocclusion, Angle Class III | Malocclusion, Angle Class I